Matches in SemOpenAlex for { <https://semopenalex.org/work/W2402857589> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W2402857589 endingPage "15S" @default.
- W2402857589 startingPage "10S" @default.
- W2402857589 abstract "Atrial fibrillation (AF) is the most common arrhythmia encountered in clinical practice and a difficult-to-treat arrhythmia. Conventional antiarrhythmic drugs, including flecainide, propafenone, sotalol and amiodarone, have several limitations in terms of efficacy and tolerability, and have made new drug development crucial. In the last decade, intensive research was undertaken to find new pharmacological options for the treatment of AF, and two new drugs are now available. Vernakalant is an atrial-selective drug specifically designed to block sodium channels at the atrial level, and its intravenous formulation has recently been recommended for approval by the Food and Drug Administration for pharmacological conversion of AF. Dronedarone is a chemical derivative of amiodarone (though having a significantly different clinical profile) with effects on multiple ion channels that proved effective in reducing the rate of the combined endpoint of death from any cause and cardiovascular hospitalization in patients with non-permanent AF enrolled in the ATHENA study. The available evidence on the efficacy of dronedarone has led to approval for recommendation in many clinical situations in which rhythm control is desirable. The complexity of the mechanisms underlying AF and the large variability of associated comorbidities render the AF patient a unique entity, making the identification of patients who may benefit from these novel approaches challenging." @default.
- W2402857589 created "2016-06-24" @default.
- W2402857589 creator A5000619566 @default.
- W2402857589 creator A5010182498 @default.
- W2402857589 creator A5014258029 @default.
- W2402857589 creator A5015139435 @default.
- W2402857589 creator A5061233034 @default.
- W2402857589 date "2012-10-01" @default.
- W2402857589 modified "2023-09-25" @default.
- W2402857589 title "[New antiarrhythmic drugs for the treatment of atrial fibrillation]." @default.
- W2402857589 doi "https://doi.org/10.1714/1167.12913" @default.
- W2402857589 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23096368" @default.
- W2402857589 hasPublicationYear "2012" @default.
- W2402857589 type Work @default.
- W2402857589 sameAs 2402857589 @default.
- W2402857589 citedByCount "0" @default.
- W2402857589 crossrefType "journal-article" @default.
- W2402857589 hasAuthorship W2402857589A5000619566 @default.
- W2402857589 hasAuthorship W2402857589A5010182498 @default.
- W2402857589 hasAuthorship W2402857589A5014258029 @default.
- W2402857589 hasAuthorship W2402857589A5015139435 @default.
- W2402857589 hasAuthorship W2402857589A5061233034 @default.
- W2402857589 hasConcept C126322002 @default.
- W2402857589 hasConcept C164705383 @default.
- W2402857589 hasConcept C177713679 @default.
- W2402857589 hasConcept C178790620 @default.
- W2402857589 hasConcept C185592680 @default.
- W2402857589 hasConcept C197934379 @default.
- W2402857589 hasConcept C2776414672 @default.
- W2402857589 hasConcept C2776639339 @default.
- W2402857589 hasConcept C2778094803 @default.
- W2402857589 hasConcept C2778375690 @default.
- W2402857589 hasConcept C2779161974 @default.
- W2402857589 hasConcept C2779177932 @default.
- W2402857589 hasConcept C2779518148 @default.
- W2402857589 hasConcept C2779837460 @default.
- W2402857589 hasConcept C2780035454 @default.
- W2402857589 hasConcept C2781472538 @default.
- W2402857589 hasConcept C50952357 @default.
- W2402857589 hasConcept C537181965 @default.
- W2402857589 hasConcept C71924100 @default.
- W2402857589 hasConcept C98274493 @default.
- W2402857589 hasConceptScore W2402857589C126322002 @default.
- W2402857589 hasConceptScore W2402857589C164705383 @default.
- W2402857589 hasConceptScore W2402857589C177713679 @default.
- W2402857589 hasConceptScore W2402857589C178790620 @default.
- W2402857589 hasConceptScore W2402857589C185592680 @default.
- W2402857589 hasConceptScore W2402857589C197934379 @default.
- W2402857589 hasConceptScore W2402857589C2776414672 @default.
- W2402857589 hasConceptScore W2402857589C2776639339 @default.
- W2402857589 hasConceptScore W2402857589C2778094803 @default.
- W2402857589 hasConceptScore W2402857589C2778375690 @default.
- W2402857589 hasConceptScore W2402857589C2779161974 @default.
- W2402857589 hasConceptScore W2402857589C2779177932 @default.
- W2402857589 hasConceptScore W2402857589C2779518148 @default.
- W2402857589 hasConceptScore W2402857589C2779837460 @default.
- W2402857589 hasConceptScore W2402857589C2780035454 @default.
- W2402857589 hasConceptScore W2402857589C2781472538 @default.
- W2402857589 hasConceptScore W2402857589C50952357 @default.
- W2402857589 hasConceptScore W2402857589C537181965 @default.
- W2402857589 hasConceptScore W2402857589C71924100 @default.
- W2402857589 hasConceptScore W2402857589C98274493 @default.
- W2402857589 hasIssue "10 Suppl 2" @default.
- W2402857589 hasLocation W24028575891 @default.
- W2402857589 hasOpenAccess W2402857589 @default.
- W2402857589 hasPrimaryLocation W24028575891 @default.
- W2402857589 hasRelatedWork W103658323 @default.
- W2402857589 hasRelatedWork W119345418 @default.
- W2402857589 hasRelatedWork W1973416160 @default.
- W2402857589 hasRelatedWork W2010627883 @default.
- W2402857589 hasRelatedWork W2102482054 @default.
- W2402857589 hasRelatedWork W2139439166 @default.
- W2402857589 hasRelatedWork W2142623725 @default.
- W2402857589 hasRelatedWork W2158180587 @default.
- W2402857589 hasRelatedWork W2402857589 @default.
- W2402857589 hasRelatedWork W2472063348 @default.
- W2402857589 hasVolume "13" @default.
- W2402857589 isParatext "false" @default.
- W2402857589 isRetracted "false" @default.
- W2402857589 magId "2402857589" @default.
- W2402857589 workType "article" @default.